0001178913-22-003374.txt : 20220909
0001178913-22-003374.hdr.sgml : 20220909
20220909160915
ACCESSION NUMBER: 0001178913-22-003374
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220907
FILED AS OF DATE: 20220909
DATE AS OF CHANGE: 20220909
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Santora Arthur C II
CENTRAL INDEX KEY: 0001904746
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38556
FILM NUMBER: 221236302
MAIL ADDRESS:
STREET 1: KIRYAT HADASSAH
STREET 2: MINRAV BUILDING, FIFTH FLOOR
CITY: JERUSALEM
STATE: L3
ZIP: 9112002
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Entera Bio Ltd.
CENTRAL INDEX KEY: 0001638097
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: KIRYAT HADASSAH, MINRAV BUILDING
STREET 2: FIFTH FLOOR
CITY: JERUSALEM
STATE: L3
ZIP: 9112002
BUSINESS PHONE: 972-2-532-7151
MAIL ADDRESS:
STREET 1: KIRYAT HADASSAH, MINRAV BUILDING
STREET 2: FIFTH FLOOR
CITY: JERUSALEM
STATE: L3
ZIP: 9112002
4
1
ownership.xml
X0306
4
2022-09-07
0
0001638097
Entera Bio Ltd.
ENTX
0001904746
Santora Arthur C II
KIRYAT HADASSAH,
MINRAV BUILDING, 5TH FLOOR
JERUSALEM
L3
9112002
ISRAEL
0
1
0
0
Chief Medical Officer
Stock Option (right to buy)
2.86
2022-09-07
4
A
0
20000
0
A
2031-03-31
Ordinary Shares, par value NIS 0.0000769 per share
20000
20000
D
This grant of options was approved by the Board of Directors of Entera Bio Ltd. (the "Company") on March 31, 2021, subject to approval by the Company's shareholders, which was obtained on September 7, 2022. The options vest over a four-year period that commenced on March 31, 2021, with 25% of the options vesting on the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining three-year period.
/s/ Dana Yaacov-Garbeli, Attorney-in-Fact
2022-09-09